OBJECTIVE: To investigate the effect of epigallocatechin-3-gallate (EGCG) on the activity of alpha-glucosidase derived from bakers' yeast and small intestinal mucosa of Wistar rats, in order to establish an evaluation system for the activity of alpha-glucosidase inhibitor. METHODS: alpha-glucosidase was prepared from the bakers' yeast and the small intestinal mucosa of Wistar rats. The inhibitory activity of EGCG on alpha-glucosidase was based on the concentration of glucose in the reaction system. RESULTS: EGCG was shown to be an alpha-glucosidase inhibitor. IC50 was 0.150 mg/ml and 0.837 mg/ml for alpha-glucosidase derived from bakers' yeast and small intestinal mucosa respectively. CONCLUSION: The establishment of an in vitro evaluation system for AGI activity is conductive for screening alpha-glucosidase inhibitory substance. The AGI activity of EGCG is strong in vitro.
|Evidence ID||Analyze ID||Interactor||Interactor Systematic Name||Interactor||Interactor Systematic Name||Type||Assay||Annotation||Action||Modification||Phenotype||Source||Reference||Note|
|Evidence ID||Analyze ID||Gene||Gene Systematic Name||Gene Ontology Term||Gene Ontology Term ID||Qualifier||Aspect||Method||Evidence||Source||Assigned On||Reference||Annotation Extension|
|Evidence ID||Analyze ID||Gene||Gene Systematic Name||Phenotype||Experiment Type||Experiment Type Category||Mutant Information||Strain Background||Chemical||Details||Reference|
|Evidence ID||Analyze ID||Regulator||Regulator Systematic Name||Target||Target Systematic Name||Experiment||Conditions||Strain||Source||Reference|